Madrigal Pharmaceuticals (MDGL) Stock Chart & Stock Price History $302.17 -0.34 (-0.11%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$300.90 -1.28 (-0.42%) As of 08/1/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Madrigal Pharmaceuticals Stock Price Performance The Madrigal Pharmaceuticals (MDGL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 9.74%, with a year-to-date return of -2.07%. In the past month, the stock has increased 1.23%, reflecting recent market activity. As of the latest close, Madrigal Pharmaceuticals traded at $302.17 with a market cap of $6.71 billion and volume of 236,785 shares. Five years ago, the stock traded at $105.63, representing a 186.06% increase over that period. At the time, it had a market cap of $1.58 billion and a volume of 89,252 shares. Receive MDGL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.64%1 Month Performance+1.23%3 Month Performance-4.22%Year-To-Date Performance-2.07%1 Year Performance+9.74%5 Year Performance+186.06% MDGL Stock Chart for Sunday, August, 3, 2025 MDGL Chart by TradingView Madrigal Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$302.51$302.17-0.11%$308.52$298.00236,785 shs$6.71 billion07/31/2025$289.88$302.51+4.36%$312.05$290.00535,494 shs$6.72 billion07/30/2025$294.40$289.88-1.54%$302.00$286.44535,365 shs$6.44 billion07/29/2025$294.16$294.40+0.08%$298.29$288.88259,851 shs$6.54 billion07/28/2025$298.40$294.16-1.42%$305.59$293.85292,476 shs$6.53 billion07/25/2025$299.17$298.40-0.26%$301.82$296.17300,049 shs$6.63 billion07/24/2025$306.76$299.17-2.47%$312.00$298.79360,081 shs$6.64 billion07/23/2025$313.40$306.76-2.12%$324.00$306.35375,227 shs$6.81 billion07/22/2025$330.94$313.40-5.30%$332.75$312.50583,499 shs$6.96 billion07/21/2025$334.13$330.94-0.95%$337.40$328.53232,216 shs$7.35 billion Get the Latest News and Ratings for MDGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$348.73$334.13-4.19%$351.20$331.24326,009 shs$7.42 billion07/17/2025$344.97$348.73+1.09%$352.00$343.00361,968 shs$7.74 billion07/16/2025$311.14$344.97+10.87%$357.91$327.151.30 million shs$7.66 billion07/15/2025$319.87$311.14-2.73%$322.50$307.43273,763 shs$6.91 billion07/14/2025$315.46$319.87+1.40%$327.59$314.57316,922 shs$7.10 billion07/11/2025$314.64$315.46+0.26%$316.97$309.62163,873 shs$7.00 billion07/10/2025$308.59$314.64+1.96%$314.86$305.02188,614 shs$6.99 billion07/09/2025$287.52$308.59+7.33%$310.00$290.61351,806 shs$6.85 billion07/08/2025$289.17$287.52-0.57%$292.29$285.00250,717 shs$6.38 billion07/07/2025$298.49$289.17-3.12%$297.81$284.02177,836 shs$6.42 billion07/04/2025$298.49$298.49$304.00$298.00108,674 shs$6.63 billion07/03/2025$300.15$298.49-0.55%$304.00$298.00108,674 shs$6.63 billion07/02/2025$300.16$300.150.00%$311.21$295.43340,912 shs$6.66 billion Related Companies Biogen Stock Chart United Therapeutics Stock Chart Incyte Stock Chart Neurocrine Biosciences Stock Chart Exelixis Stock Chart BioMarin Pharmaceutical Stock Chart Exact Sciences Stock Chart Halozyme Therapeutics Stock Chart Repligen Stock Chart Ionis Pharmaceuticals Stock Chart Receive MDGL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MDGL) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
